Centiva Capital, LP Amneal Pharmaceuticals, Inc. Transaction History

Centiva Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$5.36 - $7.11 $2,931 - $3,889	-547 Reduced 0.95%	57,139 $362,000
Q1 2024 May 15, 2024	BUY	$5.24 - $6.34 $302,274 - $365,729	57,686 New	57,686 $349,000
Q3 2023 Nov 14, 2023	BUY	$2.76 - $4.59 $88,077 - $146,476	31,912 New	31,912 $134,000
Q4 2021 Feb 14, 2022	SELL	$3.95 - $5.85 $89,870 - $133,099	-22,752 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.31 - $5.64 $98,061 - $128,321	22,752 New	22,752 $121,000

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.25B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.